Low-levels of type I interferons (IFN-I) are thought to be a driving force for immune activation and T cell exhaustion in HIV-1 infected individuals on highly active antiretroviral therapy (HAART), though the causative mechanisms for persistent IFN-I signaling have remained unclear. Here, we show Rev-CRM1 dependent nuclear export and peripheral membrane association of intron-containing HIV-1 unspliced RNA (usRNA), independent of primary viral sequence or viral protein expression, is subject to sensing, and results in IFN-I-dependent pro-inflammatory responses in macrophages.
INTRODUCTION
A hallmark of HIV-1 infection in vivo is systemic chronic immune activation (1), which has been postulated to lead to HIV-associated non-AIDS complications (HANA) (2) In this study, we report that expression and Rev-CRM1 dependent nuclear export of HIV-1 unspliced RNA (usRNA) activates host sensing mechanisms and production of type I interferon (IFN-I)-dependent pro-inflammatory responses in productively infected macrophages. Ability of cells to distinguish intron-containing HIV-1 usRNA from self mRNA was dependent on localization of non-self HIV usRNA at peripheral membrane sites. These findings suggest that novel therapeutic strategies that suppress viral usRNA expression and IFN-I signaling cascades in tissue macrophages might have immunologic and therapeutic benefit in HIV-1 infected individuals on HAART.
RESULTS

Late step of HIV-1 replication in macrophages triggers immune activation
HIV-1 infection of monocyte-derived macrophages (MDMs) results in induction of a myeloid cell specific ISG, CD169/Siglec1 (Fig 1A) (8) whose expression is dramatically up-regulated (5-fold) even upon low levels (<0.3 U/ml) of IFN-α exposure (data not shown). Pre-treatment of MDMs with HIV-1 fusion (maraviroc), reverse transcription (AZT) or integration (raltegravir) inhibitors that blocked establishment of virus infection (Fig 1B) , abrogated induction of ISGs, CD169 (Fig 1C) and IP-10 (CXCL10) (Fig 1D) .
Interestingly, inhibition of Tat-dependent transcription (flavopiridol), but not virus particle maturation (treatment with HIV-1 protease inhibitor, indinavir), in HIV-infected MDMs (Fig 1B) , blocked enhancement of CD169 expression ( Fig 1C) and secretion of IP-10
( Fig 1D) , suggesting that a post-transcriptional step in HIV-1 replication cycle activates
MDMs. Furthermore, induction of IFN-β mRNA expression in productively infected
MDMs was detected only at 3 days post infection (Fig 1E) , which was coincident with the up-regulation of CD169 (data not shown), further supporting the hypothesis that a late event in virus replication cycle induces IFN-I responses. Moreover, B18R, IFN-I neutralizing reagent, potently inhibited CD169 expression on MDMs (Fig 1G) and reduced IP-10 secretion (Fig 1H) , confirming the presence of low levels of bioactive IFN-I (below the detection limit of a highly sensitive bioassay (Fig 1I) ) in HIV-infected MDM culture supernatants that had negligible impact on virus infection (spread) (Fig   1F) . Collectively, these results suggest that host sensing of a late step of HIV-1 replication in MDMs induces IFN-I-dependent pro-inflammatory responses.
Rev-CRM1 dependent HIV-1 usRNA export is subject to host sensing mechanisms Though induction of pro-inflammatory responses have been described upon exposure to HIV-1 accessory or structural proteins in diverse cell types (9, 10) , MDMs infected with Nef, Env, Vpu, Vpr, or Vif-deficient mutants (Fig 2A) displayed robust induction of CD169 and IP-10 expression (Fig 2B and C) . Moreover, MDM infections with Gag p6 suggesting that neither virion-release (13) , cytoplasmic accumulation of higher-ordered Gag assembly intermediates nor CyPA-binding to de novo expressed Gag, a target of a "cryptic sensor" in myeloid dendritic cells (10) , is required for MDM activation.
Furthermore, complete abrogation of Gag-pol expression (ΔGag-pol; Fig 2D) only modestly attenuated expression of CD169 and IP-10 ( Fig 2U and V) in infected MDMs (Fig 2T) , suggesting that structural and accessory proteins of HIV-1 do not encode immune-activation determinants.
To identify the post-transcriptional viral product that induces pro-inflammatory responses in MDM, we next assessed the effect of viral RNA on MDM activation. There are three classes of viral mRNAs (multiply-spliced, singly-spliced and unspliced)
transcribed from the HIV-1 LTR (14) . Nuclear export of HIV-1 usRNA relies on Rev-RRE binding and a cellular mRNA transporter CRM1 (15, 16) . Mutations that disrupt Rev binding to CRM1 (M10 mutant; Fig 3A) or delete RRE (∆RRE; Fig 3A) abrogate usRNA nuclear export and thus Gag expression, but not export and translation of multiply-spliced viral RNAs (i.e. GFP in place of nef; Fig 3A, B and C) (15, 16) .
Interestingly, infection of MDMs with the M10 mutant failed to up-regulate CD169 and IP-10 expression (Fig 3D and E) . Insertion of the constitutive transporting element (CTE) from Mason-Pfizer monkey virus (MPMV) (17) within the pol open reading frame (orf) of the M10 mutant (M10-CTE) or the ∆RRE mutant (∆RRE-CTE) in the sense orientation, but not in the anti-sense orientation (M10-CTE-AS), rescued nuclear export of HIV-1 usRNA and Gag expression (Fig 3A and B) . However, rescue of HIV-1 usRNA nuclear export by CTE-dependent pathway failed to induce CD169 or IP-10 expression (Fig 3D and E) . Moreover, while Rev-dependent expression of a non-viral protein (TagRFP) from the intron-containing viral usRNA (Fig 3F and G) induced CD169 and IP-10 expression (Fig 3H and I) , Rev-independent expression of intron-less non-viral protein (ZsGreen) (Fig 3F and J (14) . To putatively alter membrane association sites of HIV-1 usRNA, we next utilized a HIV-1/MLV chimeric virus, mMA12, which contains MA and p12 of MLV in place of HIV-1 MA (Fig 4D)(19) . Interestingly, infection of MDMs with mMA12 attenuated CD169 and IP-10 expression in productively infected MDMs (Fig 4E, F and G) . Finally, infection of MDMs with myristoylationdeficient MA mutant (G2A) (Fig 4H) that prevents stable membrane association of HIV-1 Gag (12) attenuated viral usRNA-induced MDM activation (Fig 4I and J) . These results suggest that stable membrane association of viral usRNA is necessary for host sensing and induction of type I IFN-dependent pro-inflammatory signals in MDMs.
DISCUSSION
Whether HIV-1 infection of MDMs is subject to sensing has remained a matter of controversy. In this study, we show that a late step of HIV-1 replication, specifically, expression and Rev-CRM1 mediated nuclear export of viral usRNA and its peripheral membrane association in MDMs is subject to host sensing mechanisms and results in innate immune activation and induction of pro-inflammatory responses. Importantly, we hypothesize that Rev-CRM1 dependent nuclear export specifically "marks" HIV-1 usRNA for detection by cytoplasmic sensing mechanisms, since access to alternative CTE-dependent nuclear export pathway failed to induce pro-inflammatory responses.
There seems to be no sequence specificity for the sensing mechanism since inclusion with the GFP gene. Rev-deficient mutant (M10) was created by PCR-directed mutagenesis using the primer set ( Table 1) . To make RRE-deletion mutant (∆RRE), a
MATERIALS AND METHODS
Plasmids
StuI-AleI fragment in the env orf was deleted from Lai∆envGFP. The CTE was PCRamplified using the primers ( 
Immunoblot analysis
To assess expression of p24 gag , cell lysates containing 20-30 µg total protein were separated by SDS-PAGE, transferred to nitrocellulose membranes and the membranes were probed with a mouse anti-p24 antibody (p24-2, Dr. Michael H. Malim, NIH AIDS Reagent Program) followed by donkey anti-goat-IgG-IRDye 680 (Pierce). As loading controls, actin was probed using rabbit anti-actin (SIGMA) followed by a goat anti-rabbitIgG-IRDye 800CW (Pierce). Membranes were scanned with an Odessy scanner (LiCor).
mRNA quantification
Total mRNA was isolated from 1x10 6 cells using a kit (RNeasy kit, QIAGEN) and reverse-transcribed using oligo(dT) 20 primer (SuperscriptIII, Invitrogen). IFN-β mRNA was quantified using Maxima SYBR Green (Thermo Scientific) and normalized to GAPDH mRNA by the 2 -∆∆C T method as described (28, 34). As a positive control for IFN-β mRNA expression, MDMs were treated with 1 µg/ml LPS (InvivoGen) for 2 hours.
Cytokine quantification
IP-10 in MDM culture supernatants was measured with a BD Human IP-10 ELISA Set (BD). Bioactive IFN-I was measured by a bioassay using 293 ISRE-luc cell line (28).
Flow cytometry
CD169 on MDMs was stained with Alexa647-condjugated mouse anti-human CD169 antibody (BioLegend) and analyzed with BD LSRII (BD). Geo mean fluorescence intensity (MFI) was calculated and normalized to that of uninfected (mock) MDMs. In some experiments, intracellular p24 was stained as described (28) using FITC-or RD1-condjucated mouse anti-p24 monoclonal antibody (KC57, Coulter). Data was analyzed with FlowJo software (FlowJo).
Statistics
All the statistics analysis was performed using GraphPad Prism 5. Two-tailed p values were calculated using one-way ANOVA followed by the 
